Fairmount Funds Management LLC Axsome Therapeutics, Inc. Transaction History
Fairmount Funds Management LLC
- $615 Million
- Q3 2024
A detailed history of Fairmount Funds Management LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Fairmount Funds Management LLC holds 2,360,077 shares of AXSM stock, worth $234 Million. This represents 34.46% of its overall portfolio holdings.
Number of Shares
2,360,077
Previous 2,360,077
-0.0%
Holding current value
$234 Million
Previous $190 Million
11.61%
% of portfolio
34.46%
Previous 37.71%
Shares
12 transactions
Others Institutions Holding AXSM
# of Institutions
326Shares Held
37.7MCall Options Held
912KPut Options Held
855K-
Rtw Investments, LP New York, NY4.19MShares$415 Million6.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4MShares$396 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$327 Million0.01% of portfolio
-
Bvf Inc San Francisco, CA1.05MShares$104 Million2.99% of portfolio
-
Ra Capital Management, L.P. Boston, MA1MShares$99.1 Million1.25% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $4.25B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...